The immunoglobulin lambda light chain enhancer consists of three modules which synergize in activation of transcription

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 713-724

  Asenbauer, Hildegard ^a   Combriato, Gabriele ^a   Klobeck, H Gustav ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chromatin structure; Developmental regulation of chromatin structure; Human; Immunoglobulin enhancer elements; light chain enhancer module

Indexed keywords

IMMUNOGLOBULIN LAMBDA CHAIN;

ARTICLE; CHROMATIN; CONTROLLED STUDY; ENHANCER REGION; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0033032130     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<713::AID-IMMU713>3.0.CO;2-M     Document Type: Article

References (42)

1. Siminovitch, K. A., Bakhshi, A., Goldman, P. and Korsmeyer, S. J., A uniform deleting element mediates the loss of kappa genes in human B cells. Nature 1985. 316: 260-262.
2. Klobeck, H.-G. and Zachau, H. G., The human C(greek kappa symbol) gene segment and the (greek kappa symbol) deleting element are closely linked. Nucleic Acids Res. 1986. 14: 4591-4603.
3. Yancopoulos, G. D. and Alt, F. W., Regulation of the assembly and expression of variable-region genes. Annu. Rev. Immunol. 1986. 4: 339-368.
4. Sleckman, B. P., Gorman, J. R. and Alt, F. W., Accessibility control of antigen receptor variable region gene assembly: Role of cis acting elements. Annu. Rev. Immunol. 1996. 14: 459-481.
5. Banerji, I., Olson, L. and Schaffner, W., A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 1983. 33: 729-740.
6. Gillies, S. D., Morrison, S. L., Oi, V. T. and Tonegawa, S., A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 1983. 33: 717-728.
7. Takeda, S., Zou, Y. R., Bluethmann, H., Kitamura, D., Muller, U. and Rajewsky, K., Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans. EMBO J. 1993. 12: 2329-2336.
8. Meyer, K. B. and Neuberger, M. S., The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 1989. 8: 1959-1964.
9. Sharpe, M. J., Milstein, C., Jarvis, J. M. and Neuberger, M. S., Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J. 1991. 10: 2139-2145.
10. Betz, A. G., Milstein, C., Gonzalez Fernandez, A., Pannell, R., Larson, T. and Neuberger, M. S., Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell 1994. 77: 239-248.
11. Goyenechea, B., Klix, N., Yelamos, J., Williams, G. T., Riddell, A., Neuberger, M. S. and Milstein, C., Cells strongly expressing ig kappa transgenes show clonal recruitment of hypermutation: A role for both mar and the enhancers. EMBO J. 1997. 16: 3987-3994.
12. Klix, N., Jolly, C. J., Davies, S. L., Bruggemann, M., Williams, G. T. and Neuberger, M. S., Multiple sequences from downstream of the J(kappa) cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain. Eur. J. Immunol. 1998. 28: 317-326.
13. Picard, D. and Schaffner, W., A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene. Nature 1984. 307: 80-82.
14. Pettersson, S., Cook, G. P., Bruggemann, M., Williams, G. T. and Neuberger, M. S., A sceond B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus. Nature 1990. 344: 165-168.
15. Matthias, P. and Baltimore, D., The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region. Mol. Cell. Biol. 1993. 13: 1547-1553.
16. Madisen, L. and Groudine, M., Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev. 1994. 8: 2212-2226.
17. Michaelson, J. S., Giannini, S. L. and Birshtein, B. K., Identification of 3'alpha-hs4, a novel Ig chain enhancer element regulated at multiple stages of B cell differentiation. Nucleic Acids Res. 1995. 23: 975-981.
18. Giannini, S. L., Singh, M., Calvo, C. F., Ding, G. and Birshtein, B. K., DNA regions flanking the mouse Ig 3'alpha enhancer are differentially methylated and DNase I hypersensitive during B cell differentiation. J. Immunol. 1993. 150: 1772-1780.
19. Hagman, J., Rudin, C. M., Haasch, C., Chaplin, D. and Storb, U., A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B. Genes Dev. 1990. 4: 978-992.
20. Asenbauer, H. and Klobeck, H.-G., Tissue-specific deoxyribonuclease I-hypersensitive sites in the vicinity of the immunoglobulin C lambda cluster of man. Eur. J. Immunol. 1996. 26: 142-150.
21. Blomberg, B., Rudin, C. M. and Storb, U., Identification and localization of an enhancer for the human lambda L chain Ig gene complex. J. Immunol. 1991. 147: 2354-2358.
22. Fulton, R. and Van Ness, B., Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res. 1993. 21: 4941-4947.
23. Garcia, J. V., Bich Thuy, L. T., Stafford, J. and Queen, C., Synergism between immunoglobulin enhancers and promoters. Nature 1986. 322: 383-385.
24. Combriato, G. and Klobeck, H.-G., Vλ and Jλ-Cλ gene segments of the human immunoglobulin lambda light chain locus are separated by 14 kb and rearrange by a deletion mechanism. Eur. J. Immunol. 1991. 21: 1513-1522.
25. Falkner, F. G. and Zachau, H. G., Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature 1984. 310: 71-74.
26. Klobeck, H.-G., Combriato, G. and Zachau, H. G., Immunoglobulin genes of the kappa light chain type from two human lymphoid cell lines are closely related. Nucleic Acids Res. 1984. 12: 6995-7006.
27. Polack, A., Feederle, R., Klobeck, H.-G. and Hortnagel, K., Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO J. 1993. 12: 3913-3920.
28. Findley H. W., Jr., Cooper, M. D., Kim, T. H., Alvarado, C. and Ragab, A. H., Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 1982. 60: 1305-1309.
29. Xu, Y., Davidson, L., Alt, F. W. and Baltimore, D., Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa-J kappa rearrangement. Immunity 1996. 4: 377-385.
30. Gorman, J. R., van der Stoep, N., Monroe, R., Cogne, M., Davidson, L. and Alt, F. W., The Ig(greek kappa symbol) enhancer influences the ratio of Ig(greek kappa symbol) versus Igλ B lymphocytes. Immunity 1996. 5: 241-252.
31. van der Stoep, N., Gorman, J. R. and Alt, F. W., Reevaluation of the 3'E(greek kappa symbol) function in stage-and lineage-specific rearrangement and somatic hypermutation. Immunity 1998. 8: 743-750.
32. Ong, J., Stevens, S., Roeder, R. G. and Eckhardt, L. A., 3' IgH enhancer elements shift synergistic interactions during B cell development. J. Immunol. 1998. 160: 4896-4903.
33. Klein, E., Klein, G., Nadkarni, J. S., Nadkarni, J. J., Wigzell, H. and Clifford, P., Surface IgM-(greek kappa symbol)(greek kappa symbol) specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 1968. 28: 1300-1310.
34. Huang, C. C., Hou, Y., Woods, L. K., Moore, G. E. and Minowada, J., Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. J. Natl. Cancer Inst. 1974. 53: 655-660.
35. Hurwitz, R., Hozier, J., LeBien, T., Minowada, J., Gajl, P. K., Kubonishi, I. and Kersey, J., Characterization of a leukemic cell line of the pre-B phenotype. Int. J. Cancer 1979. 23: 174-180.
36. Pegoraro, L., Matera, L., Ritz, J., Levis, A., Palumbo, A. and Biagini, G., Establishment of a Ph1-positive human cell line (BV173). J. Natl. Cancer Inst. 1983. 70: 447-453.
37. Roos, G., Adams, A., Giovanella, B., Lundgren, E., Nilsson, K., Nordenson, I. and Sundstrom, C., Establishment and characterization of a human EBV-negative B cell line (MN 60). Leuk. Res. 1982. 6: 685-693.
38. Schneider, U., Schwenk, H. U. and Bornkamm, G., Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 1977. 19: 521-526.
39. Potter, H., Weir, L. and Leder, P., Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electro-poration. Proc. Natl. Acad. Sci. USA 1984. 81: 7161-7165.
40. MacGregor, G. R. and Caskey, C. T., Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 1989. 17: 2365-2365.
41. Pfeifer, G. P. and Riggs, A. D., Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permeabilized cells using DNase I and ligation-mediated PCR. Genes Dev. 1991. 5: 1102-1113.
42. Roque, M. C., Smith, P. A. and Blasquez, V. C., A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer. Mol. Cell. Biol. 1996. 16: 3138-3155.